Video

Dr. Turaga on Surgery Versus Immunotherapy in Melanoma

Kiran K. Turaga, MD, associate professor of surgery, vice chief, section of general surgery and surgical oncology, director of the Surgical GI Cancer Program and the Regional Therapeutics Program at The University of Chicago Medicine, discusses whether patients vie for immunotherapy versus surgery as treatment for their melanoma.

Kiran K. Turaga, MD, associate professor of surgery, vice chief, section of general surgery and surgical oncology, director of the Surgical GI Cancer Program and the Regional Therapeutics Program at The University of Chicago Medicine, discusses whether patients vie for immunotherapy versus surgery as treatment for their melanoma.

For primary melanomas or nonmetastatic disease, surgery still remains the standard of care, Turaga explains, adding there is little change seen. However, if there are clinical trials available for patients with metastatic melanoma, then that is the optimal choice, he says, whether it’s an immunotherapy, anti-BRAF agent, or surgical perfusional approach.

However, for patients with in-transit disease, there are issues with treatment choices. While there are therapies such as isolated limb infusions and perfusions, which are fairly low morbidity, they can be alternated for immunotherapies. These agents, he adds, have not been studied as much for in-transit disease.

Moreover, Turaga says that community oncologists should ensure that patients with melanoma receive all of their available, and appropriate, options.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 24th 2025 - Apr 25th 2026

online-activity
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Video

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Apr 23rd 2025 - Apr 24th 2026

online-activity
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Video

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Apr 23rd 2025 - Apr 24th 2026

online-activity